Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer

JAMA Otolaryngology - Head and Neck Surgery

Volumn 140, Issue 9, 2014, Pages 846-854

  Ahn, Sun M ^a   Chan, Jason Y K ^a   Zhang, Zhe ^b   Wang, Hao ^b   Khan, Zubair ^a   Bishop, Justin A ^a   Westra, William ^a   Koch, Wayne M ^a   Califano, Joseph A ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN E6; PROTEIN E7; VIRUS DNA; ONCOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CORRELATION ANALYSIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; VIRUS DETECTION; BLOOD; EARLY DIAGNOSIS; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; PROGNOSIS; SALIVA; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; EARLY DIAGNOSIS; FEASIBILITY STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; ONCOGENE PROTEINS, VIRAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 84907220422     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2014.1338     Document Type: Article

References (15)

1. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24(36):5630-5636.
2. Fakhry C,Westra WH, Li S, et al. Improved survival of patients with human papillomaviruspositive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261-269.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-4301.
4. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703.
5. Gillison ML. HPV and prognosis for patients with oropharynx cancer. Eur J Cancer. 2009;45(suppl 1):383-385.
6. Gillison M. HPV and its effect on head and neck cancer prognosis. Clin Adv Hematol Oncol. 2010;8 (10):680-682.
7. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248(4951):76-79.
8. Kessis TD, Slebos RJ, NelsonWG, et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. ProcNatl Acad Sci U S A. 1993;90(9):3988-3992.
9. Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck. 2002;24(9):841-849.
10. Capone RB, Pai SI, Koch WM, et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res. 2000;6(11):4171-4175.
11. Zhao M, Rosenbaum E, Carvalho AL, et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer. 2005;117(4):605-610.
12. Chuang AY, Chuang TC, Chang S, et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol. 2008;44(10): 915-919.
13. JohnsMMIII,Westra WH, Califano JA, Eisele D, Koch WM, Sidransky D. Allelotype of salivary gland tumors. Cancer Res. 1996;56(5):1151-1154.
14. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56 (2):337-344.
15. Vainshtein JM, SpectorME, Stenmark MH, et al. Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer. Oral Oncol. 2014;50(3):234-239.